CoChat

Epithelial-Mesenchymal Transition

Open access
Zavadil, Jiri, Haley, John, Kalluri, Raghu, Muthuswamy, Senthil K., Thompson, Erik · 2008 · Cancer Research
Cited by 143

The DOI matches its Crossref record.

Abstract

The meeting was designed to explore the intersections of signalling networks regulating and supporting epithelial-mesenchymal (EMT) and mesenchymal-epithelial transitions (MET) in development, fibrosis, and cancer. Particular emphasis was placed on correlations between tissue histology and molecular drivers and markers of EMT and on the therapeutic implications of EMT.Background. Epithelial-mesenchymal transition (EMT) was first described in three-dimensional culture of corneal epithelial cells in the laboratory of Elizabeth Hay in 1982 and has since been implicated in numerous embryonic states and pathologies including fibrotic disease and carcinogenesis. The first meeting of The EMT International Association was held in Australia in 2003 in honor of “Betty” Hay. This year's Cold Spring Harbor EMT meeting opened with a presentation by Raghu Kalluri (Beth Israel Deaconess Medical Center and Harvard Medical School, Boston, MA) to celebrate the achievements of Betty and commiserate her sad passing in 2007. The field has grown enormously since her first observations of EMT, and her profound interest and wonderful character will be sorely missed. The 2008 CSH meeting mainly focused on cancer EMT, particularly in light of recent controversies (1–3). The link between EMT and cancer plasticity has been championed by Jean-Paul Thiery (Institute of Molecular and Cell Biology, Singapore), who presented a keynote address highlighting the precise differences in the mechanical forces required to break interactions between epithelial and mesenchymal cadherins. Several talks highlighted evidence of EMT in purified breast cancer stem cells, cancers which resist therapies, and in histologically provocative locations such as the invasive front. These leave little doubt about the existence of EMT in cancer and indeed show important ramifications in metastatic competence. New evidence of EMT in breast cancer was provided by Robert Weinberg (Whitehead Institute for Biomedical Research, Cambridge, MA) and Marisa Ponzo (McGill University, Montreal, Canada). Indications for EMT in novel scenarios such as Barrett's esophagus and the human neuroendocrine tumor cell BON were proposed [Rebecca Fitzgerald (Hutchison-Medical Research Council Research Centre, Cambridge, United kingdom) and Frank Leu (Verto Institute LLC, New Brunswick, NJ)]. The presentations by Jeffrey Rosen (Baylor College of Medicine, Houston, TX), Stuart Thomson (OSI Pharmaceuticals, Farmingdale, NY), and Steven Dubinett (David Geffen School of Medicine, Los Angeles, CA) highlighted the therapeutic challenges elicited by tumor heterogeneity associated with EMT.Transcription factors. Many transcription factors driving embryonic EMT directly repress the adherens junction mediator E-cadherin through the E-box promoter elements and serve the same role in cancer. Numerous studies indicating the prognostic power of these factors in different tumor types and provocative localizations at the tumor invasive front are accruing. The definitive role of these factors in EMT regulation, along with associated behaviors of survival, migration, invasion, and resistance to anoikis, makes them prime candidates for cancer prognosis and treatment (summarized by Angela Nieto, Instituto de Neurociencias de Alicante, CSIC-UMH, San Juan de Alicante, Spain).These areas were well represented at the meeting. Andrei Bakin (Roswell Park Cancer Institute, Buffalo, NY) presented a model of EMT whereby transforming growth factor β (TGF-β) induces EMT but the ensuing metastatic and invasive properties are rendered by oncogenic H-RasV12 inhibiting the binding of Smad transducers of TGF-β to the promoter of tropomyosin TPM1, leading to nuclear export of Smad4. Low levels of TPM1 lead to destabilization of actin fibers. Aristidis Moustakas (Ludwig Institute for Cancer Research, Uppsala, Sweden) provided a comprehensive overview of how the Smad proteins facilitate the establishment of EMT, and James Woodgett (Samuel Lunenfeld Research Institute, Mount Sinai Hospital, Toronto, Canada) summarized the roles of glycogen synthase kinase 3 in cell fate determination, especially in relation to Wnt signaling, β-catenin regulation, and nuclear exportation of Snail. Novel aspects of Twist function in developmental and pathologic EMTs were presented by Carole LaBonne (Northwestern University, Evanston, IL) who showed that Twist, a bHLH transcription factor, physically and functionally interacts with numerous regulators of EMT such as Slug, Sox9, and Foxd3, acting in neural crest development as well as in tumor invasion.Many transcription factors driving EMT in development become commandeered by cancers, an observation that preempted the identification of the role of goosecoid in cancerous EMT (R. Weinberg). Exciting new talks were presented on embryonic transcription factors with roles in mammary carcinoma. Heide Ford (University of Colorado Health Sciences Center, CO) identified the homeobox gene Six1 as a regulat

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1158/0008-5472.can-08-2316

Cites

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cited by

See all 143

Metadata

Authors
Zavadil, J., Haley, J., Kalluri, R., Muthuswamy, S. K., & Thompson, E.
Venue
Cancer Research
Published
2008-12-01
Volume
68
Issue
23
Pages
9574-9577
ISSN
  • 0008-5472 (ISSN-L)
  • 1538-7445
OpenAlex
W2085265737
Cited by
143
References
0
FWCI
3.08
Type
journal article
Language
en
Open access
bronze

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Epithelial-Mesenchymal Transition. https://app.cochat.ai/papers/10.1158/0008-5472.can-08-2316
The paper
Zavadil, J., Haley, J., Kalluri, R., Muthuswamy, S. K., & Thompson, E. (2008). Epithelial-Mesenchymal Transition. Cancer Research. https://doi.org/10.1158/0008-5472.can-08-2316

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.